Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03435315
Other study ID # 2018P000014
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 9, 2019
Est. completion date October 20, 2021

Study information

Verified date May 2022
Source Beth Israel Deaconess Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to better understand the effects of two types of treadmill exercise programs that include education and/or techniques that may be helpful for exercise among individuals with, or at risk for, metabolic syndrome.


Recruitment information / eligibility

Status Terminated
Enrollment 12
Est. completion date October 20, 2021
Est. primary completion date July 7, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Referred by healthcare provider and given medical clearance for moderate-intensity exercise 2. Metabolic syndrome, defined as meeting three or more of the following criteria: - Obesity or overweight defined as BMI > 25 - Impaired glycemia (fasting blood sugar of = 100 [5.6 mmol/L] or glycated hemoglobin [A1C] of = 5.7) - Increased blood pressure (130/85 mmHg or higher) or if you take medicine for high blood pressure - Increased fasting levels of triglycerides (= 150 or 1.7 mmol/L) or decreased fasting high-density lipoprotein (HDL) cholesterol (less than 40 mg/dL or 1 mmol/L for men or 50 mg/dL or 1.3 mmol/L for women) or if you take any medicines for dyslipidemia 3. Between the ages of 18-65 4. No regular physical activity (= 3 or more days per week) for the past 3 months Exclusion Criteria: 1. Contraindications for treadmill exercise determined by their physician (e.g., cardiopulmonary limitations or diagnoses) or other inability to do treadmill exercise (e.g., musculoskeletal restrictions or severe balance impairment) 2. Confirmed diagnosis of coronary artery disease 3. Confirmed diagnosis of diabetes 4. Currently taking a beta blocker or calcium channel blocker medication 5. Uncontrolled and untreated hypertension, defined as a resting blood pressure of 150/90 6. Confirmed diagnosis of chronic obstructive pulmonary disease or other severe lung dysfunction that may interfere with exercise (e.g., severe asthma) 7. Self-reported psychotic disorder 8. Current practice of mindfulness mediation or mindful movement (e.g., yoga or tai chi), defined as regular daily practice or >2 classes or self-guided sessions per week in the past three months. 9. Non-English speaking

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Treadmill Exercise- behavioral approach
12-session, 6-week treadmill exercise program utilizing behavioral techniques while walking
Treadmill Exercise- traditional approach
12-session, 6-week traditional treadmill exercise program

Locations

Country Name City State
United States BIDMC Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Feasibility % willing to be randomized Through study completion, an average of 1 year
Primary Protocol Adherence % sessions attended Through study completion, an average of 1 year
Secondary Cardiopulmonary Dynamics CardioPulmonary Exercise Testing (standard metabolic cart) Weeks 1 and 6
Secondary Fatigue Fatigue Severity Scale-7; total score range: 7-49, higher scores = greater fatigue severity Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Global Health PROMIS Global Health-10; Global physical health total score range: 4-20, higher scores = better global physical health Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Psychological Symptoms Depression Anxiety and Stress Scale-21; Depression total score range: 0-21, higher scores = greater depressive symptoms Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Affect Positive and Negative Affect Schedule; 2 subscales; each with score range 10-50, higher = greater positive or negative affect Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Anxiety Sensitivity Anxiety Sensitivity Index-3; Total score range: 0-72, higher scores = higher levels of anxiety sensitivity Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Distress Tolerance Distress Tolerance Scale; total score range: 15-75, higher scores = higher levels of distress tolerance Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Discomfort Intolerance Discomfort Intolerance Scale-Revised; total score range: 0-126, higher scores = higher levels of discomfort intolerance Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Physical Activity Acceptance Physical Activity Acceptance Questionnaire; total score range: 10-70, higher scores = greater physical activity acceptance Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Exercise Self-Efficacy Multidimensional Self-Efficacy Scale; total score range: 0-90, higher scores = higher levels of exercise self-efficacy Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Exercise Motivation Behavioral Regulation towards Exercise Questionnaire-2; 5 subscales, each with score range: 0-16, higher scores = higher levels of regulation Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Exercise Barriers Exercise Benefits and Barriers Scale; 2 subscales; Exercise benefits subscale score range: 29-116, higher scores = higher perceived benefit from exercise; Exercise barriers subscale score range: 14-56, higher scores = higher perceived barriers to exercise Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Physical Activity Godin Leisure Time Exercise Questionnaire; open-ended responses, higher scores = greater activity time Week 0, week 3, post-intervention (after 6 week intervention)
Secondary Trait Mindfulness Five Facet Mindfulness Questionnaire; 5 subscales; Observe subscale score range: 8-40, higher scores = greater observing skills; Describe subscale score range: 8-40, higher scores = greater describing skills; Acting with Awareness subscale score range: 8-40, higher scores = greater awareness skills; Nonjudgment subscale score range: 8-40, higher scores = greater nonjudgment skills; Nonreactivity subscale score range: 7-35, higher scores = greater nonreactivity skills Week 0, week 3, post-intervention (after 6 week intervention)
Secondary State Mindfulness State Mindfulness Scale for Physical Activity; 2 subscales, each with score range: 0-24, higher scores = higher levels of mindfulness Weeks 1, 3, 6
Secondary Interoceptive Awareness Multidimensional Assessment of Interoceptive Awareness; 8 subscales, each with score ranges: 0-5, higher scores = better Week 0, week 3, post-intervention (after 6 week intervention)
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A